How Portland could be key to breakthroughs in cancer research | The Story | Sept. 12, 2024
Sept. 12 on The Story: In the early 1990s, Dr. Brian Druker was a medical researcher recruited by OHSU to head a lab focused on targeted therapies for cancers. His discovery of a treatment for a specific type of leukemia was developed into the drug Gleevac, an important development in targeted cancer treatment. Now he heads OHSU’s Knight Cancer Institute, a top research center for multiple advancements in cancer treatments. We spoke to Druker to find out what’s on the horizon in this vital field, and found out how an aspect of the product that Elizabeth Holmes and Theranos fraudulently marketed, blood tests for cancer, may soon be a reality that will revolutionize cancer detection.
Watch more The Story videos:
Follow The Story on Twitter:
Follow The Story on Instagram:
source
Thank you for sharing. I am currently taking a drug that this doctor created. Thank you and thank you ohsu.
Brown Brenda Thompson Steven Garcia Sandra
White John Thompson Cynthia Thompson Eric
KGW News, nice content you deserve more views
Fascinating Program, narrated by Pat Doris. Have a family member currently going through chemo for Breast cancer for the second time. Thank you for doing this program!